Stratagene Files Appeal, Supersedeas Bond in Invitrogen Case; Court Rejects Renewed Motion | GenomeWeb
In the latest development in the ongoing litigation between Stratagene and Invitrogen, Stratagene last week filed a notice of appeal, a supersedeas bond, and a renewed motion to have an Invitrogen patent at the center of the case declared invalid.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.